214 related articles for article (PubMed ID: 11702513)
1. Early intervention in psychotic relapse.
Birchwood M; Spencer E
Clin Psychol Rev; 2001 Nov; 21(8):1211-26. PubMed ID: 11702513
[TBL] [Abstract][Full Text] [Related]
2. Psychiatrist's adherence: a new factor in relapse prevention of schizophrenia. A randomized controlled study on relapse control through telemedicine system.
Spaniel F; Novak T; Bankovska Motlova L; Capkova J; Slovakova A; Trancik P; Matejka M; Höschl C
J Psychiatr Ment Health Nurs; 2015 Dec; 22(10):811-20. PubMed ID: 26176646
[TBL] [Abstract][Full Text] [Related]
3. Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders.
Larson MK; Walker EF; Compton MT
Expert Rev Neurother; 2010 Aug; 10(8):1347-59. PubMed ID: 20662758
[TBL] [Abstract][Full Text] [Related]
4. [Pre-psychotic states--contemporary diagnostic and therapeutic issues. Part I. Clinical identification of pre-psychotic states].
Czernikiewicz A; Szulc A
Psychiatr Pol; 2007; 41(1):5-15. PubMed ID: 17494410
[TBL] [Abstract][Full Text] [Related]
5. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
[TBL] [Abstract][Full Text] [Related]
6. [Relapse in schizophrenia: an exploratory study of the joint conceptions of patients, parents and caregivers].
Koenig M; Castillo MC; Urdapilleta I; Le Borgne P; Bouleau JH
Encephale; 2011 Jun; 37(3):207-16. PubMed ID: 21703436
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the relapse predictive validity of prodromal symptoms in schizophrenia.
Gaebel W; Riesbeck M
Schizophr Res; 2007 Sep; 95(1-3):19-29. PubMed ID: 17630253
[TBL] [Abstract][Full Text] [Related]
8. Training to recognise the early signs of recurrence in schizophrenia.
Morriss R; Vinjamuri I; Faizal MA; Bolton CA; McCarthy JP
Cochrane Database Syst Rev; 2013 Feb; (2):CD005147. PubMed ID: 23450559
[TBL] [Abstract][Full Text] [Related]
9. [Psychosis prevention: expectations met].
Bechdolf A; Peukert R
Psychiatr Prax; 2011 Feb; 38(2):58-60. PubMed ID: 21394689
[No Abstract] [Full Text] [Related]
10. Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?
Gaebel W; Frick U; Köpcke W; Linden M; Müller P; Müller-Spahn F; Pietzcker A; Tegeler J
Br J Psychiatry Suppl; 1993 Sep; (21):8-12. PubMed ID: 8105814
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse.
Beasley CM; Sutton VK; Hamilton SH; Walker DJ; Dossenbach M; Taylor CC; Alaka KJ; Bykowski D; Tollefson GD;
J Clin Psychopharmacol; 2003 Dec; 23(6):582-94. PubMed ID: 14624189
[TBL] [Abstract][Full Text] [Related]
12. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
[TBL] [Abstract][Full Text] [Related]
13. [Early detection and intervention in childhood and adolescent psychoses].
Adam C; Lehmkuhl G
Z Arztl Fortbild Qualitatssich; 2002 Oct; 96(9):579-85. PubMed ID: 12474308
[TBL] [Abstract][Full Text] [Related]
14. The phenomenological model of psychotic vulnerability and its possible implications for psychological interventions in the ultra-high risk ('prodromal') population.
Nelson B; Sass LA; Skodlar B
Psychopathology; 2009; 42(5):283-92. PubMed ID: 19609098
[TBL] [Abstract][Full Text] [Related]
15. [A psychological early intervention program for the prepsychotic prodromal state. A case report].
Bechdolf A; Maier S; Knost B; Wagner M; Hambrecht M
Nervenarzt; 2003 May; 74(5):436-9. PubMed ID: 12966818
[TBL] [Abstract][Full Text] [Related]
16. [Schizophrenia and psychosis--prevention and outcome].
Nordentoft M
Ugeskr Laeger; 2008 Sep; 170(37):2872-4. PubMed ID: 18796281
[TBL] [Abstract][Full Text] [Related]
17. Predicting and preventing symptom onset and relapse in schizophrenia-A metareview of current empirical evidence.
Lecomte T; Potvin S; Samson C; Francoeur A; Hache-Labelle C; Gagné S; Boucher J; Bouchard M; Mueser KT
J Abnorm Psychol; 2019 Nov; 128(8):840-854. PubMed ID: 31343181
[TBL] [Abstract][Full Text] [Related]
18. A program for relapse prevention in schizophrenia: a controlled study.
Herz MI; Lamberti JS; Mintz J; Scott R; O'Dell SP; McCartan L; Nix G
Arch Gen Psychiatry; 2000 Mar; 57(3):277-83. PubMed ID: 10711914
[TBL] [Abstract][Full Text] [Related]
19. Cognitive-behavioral therapy for medication-resistant symptoms.
Garety PA; Fowler D; Kuipers E
Schizophr Bull; 2000; 26(1):73-86. PubMed ID: 10755670
[TBL] [Abstract][Full Text] [Related]
20. TDCS produces incremental gain when combined with working memory training in patients with schizophrenia: A proof of concept pilot study.
Nienow TM; MacDonald AW; Lim KO
Schizophr Res; 2016 Apr; 172(1-3):218-9. PubMed ID: 26852404
[No Abstract] [Full Text] [Related]
[Next] [New Search]
